PROFILPELAJAR.COM

Hexedrone
Names
	IUPAC name 2-(Methylamino)-1-phenylhexan-1-one
	Other names Hexedrone, HEX
Identifiers
CAS Number	2169446-41-5 ;
3D model (JSmol)	Interactive image;
PubChem CID	129844496;
UNII	KLF7T8YQP5 ;
CompTox Dashboard (EPA)	DTXSID601336034 ;
	InChI InChI=1S/C13H19NO/c1-3-4-10-12(14-2)13(15)11-8-6-5-7-9-11/h5-9,12,14H,3-4,10H2,1-2H3 Key: BHIZKPHLTVLXIV-UHFFFAOYSA-N;
	SMILES CCCCC(C(=O)C1=CC=CC=C1)NC;
Properties
Chemical formula	C13H18NO
Molar mass	204.293 g·mol−1
Appearance	White crystalline solid
	Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references

Hexadrone is a stimulant of the substituted cathinone class which has been sold as a designer drug.^[1] Through analysis of the Structure-Activity Relationships in similar cathinones such as MDPV, hexedrone is believed to be a norepinephrine–dopamine reuptake inhibitor.

Subjective effects include stimulation, disinhibition, thought acceleration and euphoria.

Little is known about toxicity, addiction, and abuse potential of hexedrone. Due to its novelty and extremely short history of human usage, all information related to the use of this compound should be treated with caution.

Legal status

In the UK, Hexedrone is a Class B drug under The Misuse of Drugs Act 1971 (Amendment) Order 2010 following the ACMD's report on substituted cathinone derivatives,^[2] making it illegal to sell, buy, or possess without a license.^[3]^[4]

References

^ Błażewicz, Agata; Bednarek, Elżbieta; Sitkowski, Jerzy; Popławska, Magdalena; Stypułkowska, Karolina; Bocian, Wojciech; Kozerski, Lech (2017). "Identification and structural characterization of four novel synthetic cathinones: α-methylaminohexanophenone (Hexedrone, HEX), 4-bromoethcathinone (4-BEC), 4-chloro-α-pyrrolidinopropiophenone (4-Cl-PPP), and 4-bromo-α-pyrrolidinopentiophenone (4-Br-PVP) after their seizures". Forensic Toxicology. 35 (2): 317–332. doi:10.1007/s11419-017-0360-2.
^ "ACMD Consideration of The Cathinones". ACMD. 31 March 2010.
^ "A change to the Misuse of Drugs Act 1971 : Control of mephedrone and other cathinone derivatives". Home Office. 16 April 2010. Archived from the original on 25 January 2013.{{cite web}}: CS1 maint: bot: original URL status unknown (link)
^ "The Misuse of Drugs Act 1971 (Amendment) Order 2010". Home Office. 12 April 2010.